Thyrocare Technologies, the Diagnostic laboratories today disclosed a 22 per cent rise in its consolidated net profit to Rs 20.23 crore for the second quarter ended September 30. The company had noted a net profit after taxes and minority interest of Rs 16.56 crore for the same period of the previous financial year, Thyrocare Technologies said in a filing to BSE. Consolidated total income from operations also increased to Rs 78.71 crore for the quarter under consideration as compared to Rs 62.26 crore for the corresponding period year ago.
During the second half of 26th Oct’s trading session, Thyrocare share price rolled below 0.48 per cent. The stock opened at Rs. 669 as compared to its previous closing at Rs. 651.85. The stock touched the days high and low at Rs. 669 and Rs.647.15 respectively. Approximately 24,154 shares are traded in the counter with a traded value of Rs.158.49 lacs, as per NSE.
Thyrocare share price touched its 52 week high value at Rs. 684.80 on 24th Oct ’16 whereas the 52 week low value is seen at Rs. 523.20 on 24th June ‘16. The Average Daily Movement of the stock is 21.88 and its average volume for last 20 days is 72696. The stock yields 6.74 per cent monthly returns. The market cap of the company amounts to Rs. 3501.97 (Cr) and has a book value of Rs. 69.87.
Thyrocare is analyzed by Dynamic Levels researchers and analysts as the top 500 performing stocks for the current quarter among the 1700 stocks which are listed on the National Stock Exchange (NSE).Thyrocare is fundamentally strong and is safe for investment, as per Dynamic analysts.
In order to know about the support and resistance levels of the scrip and also its fundamentals and financials, please a pay a visit to Thyrocare share price history.
No comments:
Post a Comment